The two injectable medications, developed to manage diabetes, have gained popularity for weight loss. Attorneys for Jaclyn Bjorklund claim that the 44-year-old woman used Ozempic for more than a year until around July 2023 and then began using Mounjaro. She is suing the makers of both drugs, Novo Nordisk and Eli Lilly, for failing to warn of the risk of severe gastrointestinal events that could be caused by taking the medications.
Separately from the new lawsuit, CNN has reported on warnings from patients and doctors of gastroparesis and other side effects after taking Wegovy and Ozempic for weight loss or diabetes. Stomach paralysis, or the slowing of the stomach from emptying, may lead to nausea and vomiting in some patients. It can have many causes, including diabetes, which is a reason many people take drugs. Women are known to be at higher risk for the condition.